Evoke plc (LON:EVOK – Get Free Report) shares fell 10% during mid-day trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares traded hands during trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analysts Set New Price Targets
EVOK has been the topic of several research reports. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a research report on Monday, December 16th. Berenberg Bank dropped their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a report on Wednesday, December 4th.
View Our Latest Report on EVOK
Evoke Stock Performance
Evoke (LON:EVOK – Get Free Report) last released its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. As a group, research analysts predict that Evoke plc will post 12.7648305 EPS for the current year.
Insider Buying and Selling at Evoke
In related news, insider Andrea Gisle Joosen acquired 14,572 shares of the stock in a transaction dated Tuesday, January 28th. The shares were acquired at an average price of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Corporate insiders own 27.00% of the company’s stock.
About Evoke
Featured Articles
- Five stocks we like better than Evoke
- What Does Downgrade Mean in Investing?
- MarketBeat Week in Review – 03/24 – 03/28
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Stock Market Sectors: What Are They and How Many Are There?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.